Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

BACKGROUND: Fc gamma receptor polymorphisms were linked to outcome in follicular lymphoma patients treated with single-agent rituximab, an anti-CD20 monoclonal antibody. In particular, 158F/F genotype of Fc gamma receptor 3A and 131R/R genotype of Fc gamma receptor 2A correlated with worse outcome c...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Persky, Daniel O., Dornan, David, Goldman, Bryan H., Braziel, Rita M., Fisher, Richard I., LeBlanc, Michael, Maloney, David G., Press, Oliver W., Miller, Thomas P., Rimsza, Lisa M.
Формат: Artigo
Язык:Inglês
Опубликовано: Ferrata Storti Foundation 2012
Предметы:
Original Articles and Brief Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366663/
https://ncbi.nlm.nih.gov/pubmed/22271896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.050419
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы